Isomerase Therapeutics Ltd.
PrivateLast Round
Corporate Funding
Aug 15, 2016
Est. Valuation
$15.2M
Total Funding Raised
$3.49M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Isomerase Therapeutics Ltd. is a biotechnology company that provides drug discovery, synthetic biology, and bioprocess development services for pharmaceutical, agricultural, and industrial applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Isomerase Therapeutics Ltd. Comparables
Compare Isomerase Therapeutics Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Generare | 84% | |
| Hypha Discovery | 81% | |
| Ingenza Ltd | 78% | |
Isomerase Therapeutics Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Aug 15, 2016 | ||||
| Grant | Jun 3, 2016 | ||||
| Strategic | Jan 13, 2016 | ||||
| Grant | Mar 1, 2015 | ||||
| Seed | Apr 4, 2013 |
Key People
Founding team and executive leadership
Isomerase Therapeutics Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EPSRC | Grant |
| Innovate UK | Grant |
| Biotechnology and Biological Sciences Research Council | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 90% MoM, reaching 5.4K.
- Sep 16, 2025
Partnering with Regeneron and Abzena on novel payload exploration.
Isomerase Therapeutics Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Isomerase Therapeutics Ltd.'s valuation, stock price, and market status.